Skip to main content

Full Schedule

Full Schedule

  • Friday, March 18, 2022
  • 9:00 AM – 10:45 AM
    Session I: Thyroid I
    Time Zone: EDT

    Faculty: Naifa L. Busaidy, MD, FACE, FACP – The University of Texas, MD Anderson Cancer Center

    Faculty: Erik Blomain, MD, PhD – Stanford University

    Faculty: Francis P. Worden, MD – University of Michigan/Rogel Cancer Center

  • 9:00 AM – 9:05 AM
    Welcome and Polling
    Time Zone: EDT

    Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

  • 9:25 AM – 9:45 AM
    Novel Uses of Radiation in Thyroid Cancer
    Time Zone: EDT

    Speaker: Erik Blomain, MD, PhD – Stanford University

  • 9:45 AM – 10:10 AM
    Case Discussion: Recurrent Follicular Thyroid Cancer
    Time Zone: EDT

    Moderator: Naifa L. Busaidy, MD, FACE, FACP – The University of Texas, MD Anderson Cancer Center

    Panelist: Francis P. Worden, MD – University of Michigan/Rogel Cancer Center

  • 10:45 AM – 10:55 AM
    Break
    Time Zone: EDT
  • 11:35 AM – 11:45 AM
    Break
    Time Zone: EDT
  • 11:45 AM – 1:10 PM
    Session II: Thyroid II
    Time Zone: EDT

    Faculty: Theresa Guo, MD – University of California, San Diego

    Faculty: Mark Zafereo, MD – MD Anderson Cancer Center

    Faculty: Francis P. Worden, MD – University of Michigan/Rogel Cancer Center

  • 12:10 PM – 12:30 PM
    State of the Art Anaplastic Thyroid Cancer
    Time Zone: EDT

    Speaker: Mark Zafereo, MD – MD Anderson Cancer Center

  • 12:30 PM – 12:50 PM
    Debate: Follicular Thyroid Cancer: VEGF or VEGF + I/O - VEGF
    Time Zone: EDT

    Debate Speaker: Francis P. Worden, MD – University of Michigan/Rogel Cancer Center

  • 12:50 PM – 1:10 PM
    Q&A and Polling
    Time Zone: EDT

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Panelist: Theresa Guo, MD – University of California, San Diego

    Panelist: Mark Zafereo, MD – MD Anderson Cancer Center

    Panelist: Francis P. Worden, MD – University of Michigan/Rogel Cancer Center

  • 1:10 PM – 1:20 PM
    Break
    Time Zone: EDT
  • 1:20 PM – 2:50 PM
    Session III: Sarcomas I
    Time Zone: EDT

    Faculty: Nam Bui, MD – Stanford University

    Faculty: Candace L. Haddox, MD – Dana-Farber Cancer Institute

  • 1:20 PM – 1:25 PM
    Welcome and Polling
    Time Zone: EDT

    Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

  • 1:55 PM – 2:25 PM
    Novel and Targeted Therapies in Soft Tissue Sarcoma
    Time Zone: EDT

    Speaker: Candace L. Haddox, MD – Dana-Farber Cancer Institute

  • 2:25 PM – 2:50 PM
    Q&A and Polling
    Time Zone: EDT

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Panelist: Candace L. Haddox, MD – Dana-Farber Cancer Institute

    Panelist: Nam Bui, MD – Stanford University

  • 2:50 PM – 3:00 PM
    Break
    Time Zone: EDT
  • 4:55 PM – 5:00 PM
    Concluding Remarks
    Time Zone: EDT
  • 3:00 PM – 5:00 PM
    Session IV: Sarcomas II
    Time Zone: EDT

    Faculty: Brian A. Van Tine, MD, PhD – Washington University in St. Louis

    Faculty: Erik Blomain, MD, PhD – Stanford University

    Faculty: Candace L. Haddox, MD – Dana-Farber Cancer Institute

    Faculty: Nam Bui, MD – Stanford University

    Faculty: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

  • 3:25 PM – 3:30 PM
    Debate: Management of Retroperitoneal Sarcoma: Surgery Upfront vs Neoadjuvant Therapy - DISCUSSION
    Time Zone: EDT

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Panelist: Erik Blomain, MD, PhD – Stanford University

    Panelist: Brian A. Van Tine, MD, PhD – Washington University in St. Louis

  • 3:40 PM – 3:50 PM
    Debate: Systemic Therapy of Advanced Sarcoma: Is I/O Ready for Prime Time? - NO (CHEMOTHERAPY)
    Time Zone: EDT

    Debate Speaker: Nam Bui, MD – Stanford University

  • 3:55 PM – 4:25 PM
    Case Discussion: Management of a Desmoid Tumor
    Time Zone: EDT

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Panelist: Nam Bui, MD – Stanford University

    Panelist: Candace L. Haddox, MD – Dana-Farber Cancer Institute

    Panelist: Brian A. Van Tine, MD, PhD – Washington University in St. Louis

  • Friday, May 6, 2022
  • 1:00 PM – 2:25 PM
    Session I: Neuroblastoma I
    Time Zone: EDT

    Presenter: Susan L. Cohn, MD – University of Chicago Medicine

    Session Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center

    Presenter: Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto

    Presenter: Andy D. J Pearson, MD – Institute of Cancer Research, Royal Marsden Hospital, London

  • 1:00 PM – 1:05 PM
    Welcome and Polling
    Time Zone: EDT

    Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center

  • 1:05 PM – 1:25 PM
    Genomics and Genetics of Neuroblastoma
    Time Zone: EDT

    Speaker: Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto

  • 1:25 PM – 1:45 PM
    New Developments in Relapsed and Refractory Neuroblastoma
    Time Zone: EDT

    Speaker: Susan L. Cohn, MD – University of Chicago Medicine

  • 1:45 PM – 2:05 PM
    Treatment for Stage 3 Neuroblastoma in Patients > 18 Months
    Time Zone: EDT

    Speaker: Andy D. J Pearson, MD – Institute of Cancer Research, Royal Marsden Hospital, London

  • 2:05 PM – 2:25 PM
    Q&A and Polling
    Time Zone: EDT

    Panelist: Susan L. Cohn, MD – University of Chicago Medicine

    Panelist: Andy D. J Pearson, MD – Institute of Cancer Research, Royal Marsden Hospital, London

    Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center

  • 2:25 PM – 2:35 PM
    Break
    Time Zone: EDT
  • 2:35 PM – 3:35 PM
    Non-CME Innovation Theater
    Time Zone: EDT
  • 3:35 PM – 3:45 PM
    Break
    Time Zone: EDT
  • 3:45 PM – 5:15 PM
    Session II: Neuroblastoma II
    Time Zone: EDT

    Session Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center

    Presenter: Tara Henderson, MD, MPH – University of Chicago

    Presenter: Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto

  • 3:45 PM – 3:50 PM
    Welcome and Polling
    Time Zone: EDT

    Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center

  • 3:50 PM – 4:10 PM
    Managing Toxicity of Neuroblastoma Therapy
    Time Zone: EDT

    Speaker: Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto

  • 4:10 PM – 4:30 PM
    Survivorship in Neuroblastoma Patients
    Time Zone: EDT

    Speaker: Tara Henderson, MD, MPH – University of Chicago

  • 4:30 PM – 4:50 PM
    Chemoimmunotherapy as First Line Therapy of Neuroblastoma
    Time Zone: EDT

    Speaker: Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto

  • 4:50 PM – 5:10 PM
    Q&A and Polling
    Time Zone: EDT

    Panelist: Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto

    Panelist: Tara Henderson, MD, MPH – University of Chicago

    Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center

  • 5:10 PM – 5:15 PM
    Concluding Remarks
    Time Zone: EDT

    Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center

  • Friday, June 17, 2022
  • 1:00 PM – 2:35 PM
    Session I: WM I
    Time Zone: ET

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Presenter: Prashant Kapoor, MD – Mayo Clinic

    Presenter: Leo I. Gordon, MD – Northwestern University Feinberg School of Medicine

    Presenter: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute

  • 1:00 PM – 1:05 PM
    Welcome and Polling
    Time Zone: ET

    Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

  • 1:05 PM – 1:25 PM
    The Genomics of Waldenström Macroglobulinemia
    Time Zone: ET

    Speaker: Prashant Kapoor, MD – Mayo Clinic

  • 1:25 PM – 1:45 PM
    Current and Emerging Treatment Options in Waldenström Macroglobulinemia
    Time Zone: ET

    Speaker: Leo I. Gordon, MD – Northwestern University Feinberg School of Medicine

  • 1:45 PM – 1:52 PM
    Debate: BTK Inhibitors vs Bendamustine-Rituximab (BR) as Primary Therapy - BR
    Time Zone: ET

    Speaker: Prashant Kapoor, MD – Mayo Clinic

  • 1:52 PM – 1:59 PM
    Debate: BTK Inhibitors vs Bendamustine-Rituximab (BR) as Primary Therapy - BTK
    Time Zone: ET

    Debate Speaker: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute

  • 1:59 PM – 2:05 PM
    Debate: BTK Inhibitors vs Bendamustine-Rituximab (BR) as Primary Therapy - DISCUSSION
    Time Zone: ET

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Panelist: Prashant Kapoor, MD – Mayo Clinic

    Panelist: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute

  • 2:05 PM – 2:35 PM
    Q&A and Polling
    Time Zone: ET

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Panelist: Leo I. Gordon, MD – Northwestern University Feinberg School of Medicine

    Panelist: Prashant Kapoor, MD – Mayo Clinic

    Panelist: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute

  • 2:35 PM – 2:55 PM
    Break
    Time Zone: ET
  • 2:55 PM – 4:30 PM
    Session II: WM II
    Time Zone: ET

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Presenter: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute

    Presenter: Julie Richardson – International Waldenstrom’s Macroglobulinemia Foundation

    Presenter: Prashant Kapoor, MD – Mayo Clinic

    Presenter: Shayna Sarosiek, MD – Dana Farber Cancer Institute

  • 2:55 PM – 3:00 PM
    Welcome and Polling
    Time Zone: ET

    Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

  • 3:00 PM – 3:20 PM
    Role of BTK inhibitors in Waldenström Macroglobulinemia
    Time Zone: ET

    Speaker: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute

  • 3:20 PM – 3:40 PM
    Treatment Adherence: A Patient's Perspective
    Time Zone: ET

    Speaker: Julie Richardson – International Waldenstrom’s Macroglobulinemia Foundation

  • 3:40 PM – 4:00 PM
    Case Discussion: When to Wait and When to Treat
    Time Zone: ET

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Panelist: Prashant Kapoor, MD – Mayo Clinic

    Panelist: Shayna Sarosiek, MD – Dana Farber Cancer Institute

  • 4:00 PM – 4:30 PM
    Q&A and Polling
    Time Zone: ET

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Panelist: Prashant Kapoor, MD – Mayo Clinic

    Panelist: Shayna Sarosiek, MD – Dana Farber Cancer Institute

    Panelist: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute

  • Friday, September 16, 2022
  • 9:00 AM – 9:05 AM
    Welcome and Polling
    Time Zone: EDT

    Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

  • 9:00 AM – 11:40 AM
    Session I: Sarcomas I
    Time Zone: EDT

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Presenter: Nam Bui, MD – Stanford University

    Presenter: Candace L. Haddox, MD – Dana-Farber Cancer Institute

  • 9:05 AM – 9:35 AM
    Classification of Sarcomas
    Time Zone: EDT

    Speaker: Nam Bui, MD – Stanford University

  • 9:35 AM – 10:00 AM
    Novel and Targeted Therapies in Soft Tissue Sarcoma
    Time Zone: EDT

    Speaker: Candace L. Haddox, MD – Dana-Farber Cancer Institute

  • 10:00 AM – 10:30 AM
    Q&A and Polling
    Time Zone: EDT

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Panelist: Candace L. Haddox, MD – Dana-Farber Cancer Institute

    Panelist: Nam Bui, MD – Stanford University

  • 10:30 AM – 10:40 AM
    Exhibit Hall
    Time Zone: EDT
  • 10:40 AM – 11:40 AM
    Non-CME Innovation Theater (Sponsored by Aadi Bioscience)
    Time Zone: EDT
  • 11:40 AM – 11:50 AM
    Exhibit Hall
    Time Zone: EDT
  • 1:35 PM – 1:40 PM
    Concluding Remarks
    Time Zone: EDT

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

  • 11:50 AM – 1:40 PM
    Session II: Sarcomas II
    Time Zone: EDT

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Presenter: Brian A. Van Tine, MD, PhD – Washington University in St. Louis

    Presenter: Erik Blomain, MD, PhD – Stanford University

    Presenter: Candace L. Haddox, MD – Dana-Farber Cancer Institute

    Presenter: Nam Bui, MD – Stanford University

  • 11:50 AM – 11:55 AM
    Welcome and Polling
    Time Zone: EDT

    Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

  • 11:55 AM – 12:02 PM
    Debate: Management of Retroperitoneal Sarcoma: Surgery Upfront vs Neoadjuvant Therapy - SURGERY
    Time Zone: EDT

    Debate Speaker: Brian A. Van Tine, MD, PhD – Washington University in St. Louis

  • 12:02 PM – 12:10 PM
    Debate: Management of Retroperitoneal Sarcoma: Surgery Upfront vs Neoadjuvant Therapy - NEOADJUVANT THERAPY
    Time Zone: EDT

    Debate Speaker: Erik Blomain, MD, PhD – Stanford University

  • 12:10 PM – 12:15 PM
    Debate: Management of Retroperitoneal Sarcoma: Surgery Upfront vs Neoadjuvant Therapy - DISCUSSION
    Time Zone: EDT

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Panelist: Erik Blomain, MD, PhD – Stanford University

    Panelist: Brian A. Van Tine, MD, PhD – Washington University in St. Louis

  • 12:15 PM – 12:22 PM
    Debate: Systemic Therapy of Advanced Sarcoma: Is I/O Ready for Prime Time? - YES (I/O)
    Time Zone: EDT

    Debate Speaker: Candace L. Haddox, MD – Dana-Farber Cancer Institute

  • 12:22 PM – 12:30 PM
    Debate: Systemic Therapy of Advanced Sarcoma: Is I/O Ready for Prime Time? - NO (CHEMOTHERAPY)
    Time Zone: EDT

    Debate Speaker: Nam Bui, MD – Stanford University

  • 12:30 PM – 12:35 PM
    Debate: Systemic Therapy of Advanced Sarcoma: Is I/O Ready for Prime Time? - DISCUSSION
    Time Zone: EDT

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Panelist: Candace L. Haddox, MD – Dana-Farber Cancer Institute

    Panelist: Nam Bui, MD – Stanford University

  • 12:35 PM – 1:05 PM
    Case Discussion: Management of a Desmoid Tumor
    Time Zone: EDT

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Panelist: Nam Bui, MD – Stanford University

    Panelist: Candace L. Haddox, MD – Dana-Farber Cancer Institute

    Panelist: Brian A. Van Tine, MD, PhD – Washington University in St. Louis

  • 1:05 PM – 1:35 PM
    Q&A and Polling
    Time Zone: EDT

    Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

    Panelist: Nam Bui, MD – Stanford University

    Panelist: Brian A. Van Tine, MD, PhD – Washington University in St. Louis

    Panelist: Candace L. Haddox, MD – Dana-Farber Cancer Institute

    Panelist: Erik Blomain, MD, PhD – Stanford University